KYMR – Kymera Therapeutics, Inc.

KYMR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.96

Margin Of Safety %

Put/Call OI Ratio

0.64

EPS Next Q Diff

-0.03

EPS Last/This Y

-0.24

EPS This/Next Y

-1.19

Price

127.01

Target Price

145.22

Analyst Recom

1.25

Performance Q

8.33

Upside

-137.0%

Beta

2.03

Ticker: KYMR

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	KYMR	106.67	0.84	1.93	13391
2026-10-14	KYMR	106.84	0.84	0.06	13423
2026-10-15	KYMR	107.99	0.85	0.00	13384
2026-10-16	KYMR	104.65	0.83	0.04	13558
2026-10-19	KYMR	108.04	0.82	0.25	13556
2026-10-20	KYMR	113.39	0.82	0.22	13599
2026-10-21	KYMR	112.56	0.82	0.69	13731
2026-10-22	KYMR	110.98	0.82	1.60	13800
2026-10-23	KYMR	110.68	0.82	0.04	13836
2026-10-26	KYMR	113.61	0.82	0.24	13851
2026-10-27	KYMR	117.53	0.82	0.20	13870
2026-10-28	KYMR	122.58	0.81	0.72	14014
2026-10-29	KYMR	122.75	0.81	1.87	14148
2026-10-30	KYMR	126.75	0.80	2.27	14045
2026-11-02	KYMR	127.64	0.79	2.71	14095
2026-11-03	KYMR	127.1	0.79	0.03	14156
2026-11-04	KYMR	136.35	0.71	1.53	15159
2026-11-05	KYMR	128.49	0.71	0.85	15343
2026-11-06	KYMR	131.73	0.71	0.04	15356
2026-11-09	KYMR	138.99	0.72	0.23	15297
2026-11-10	KYMR	136.67	0.64	1.30	17701
2026-11-11	KYMR	135.47	0.64	0.11	17814
2026-11-12	KYMR	127.02	0.64	0.06	17925
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	KYMR	106.85	-34.7	-	-3.85
2026-10-14	KYMR	106.93	-34.7	-	-3.85
2026-10-15	KYMR	108.07	-34.7	-	-3.85
2026-10-16	KYMR	104.71	-34.7	-	-3.85
2026-10-19	KYMR	108.04	-34.7	-	-3.85
2026-10-20	KYMR	108.04	-34.7	-	-3.85
2026-10-21	KYMR	113.43	-34.7	-	-3.85
2026-10-22	KYMR	110.84	-34.7	-	-3.85
2026-10-23	KYMR	110.72	-34.7	-	-3.85
2026-10-26	KYMR	114.83	-34.7	-	-3.85
2026-10-27	KYMR	117.54	-34.7	-	-3.85
2026-10-28	KYMR	122.54	-34.7	-	-3.85
2026-10-29	KYMR	122.63	-34.7	-	-3.85
2026-10-30	KYMR	126.74	-34.7	-	-3.85
2026-11-02	KYMR	127.60	-28.7	-	-3.85
2026-11-03	KYMR	127.14	-28.4	-	-3.88
2026-11-04	KYMR	136.26	-28.4	-	-3.88
2026-11-05	KYMR	128.13	-28.4	-	-3.88
2026-11-06	KYMR	131.70	-28.5	-	-3.88
2026-11-09	KYMR	138.83	-28.5	-	-3.88
2026-11-10	KYMR	136.63	-31.3	-	-3.93
2026-11-11	KYMR	134.90	-31.3	-	-3.93
2026-11-12	KYMR	127.01	-31.3	-	-3.93
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	KYMR	-30.18	0.95	13.29
2026-10-14	KYMR	-30.18	0.95	13.29
2026-10-15	KYMR	-30.18	0.95	13.29
2026-10-16	KYMR	-30.18	0.95	13.29
2026-10-19	KYMR	-30.30	0.91	13.27
2026-10-20	KYMR	-30.30	0.91	13.27
2026-10-21	KYMR	-30.30	0.91	13.27
2026-10-22	KYMR	-30.30	0.91	13.27
2026-10-23	KYMR	-30.30	0.91	13.27
2026-10-26	KYMR	-30.27	0.86	13.27
2026-10-27	KYMR	-30.27	0.86	12.28
2026-10-28	KYMR	-30.27	0.86	12.28
2026-10-29	KYMR	-30.27	0.86	12.28
2026-10-30	KYMR	-30.10	0.86	12.28
2026-11-02	KYMR	-29.54	0.17	11.96
2026-11-03	KYMR	-29.54	0.17	11.96
2026-11-05	KYMR	-29.54	0.17	11.96
2026-11-06	KYMR	-29.54	0.17	11.96
2026-11-09	KYMR	-29.54	-0.22	11.96
2026-11-10	KYMR	-29.54	-0.22	11.96
2026-11-11	KYMR	-29.54	-0.22	10.96
2026-11-12	KYMR	-29.53	-0.22	10.96
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-1.32

Avg. EPS Est. Current Quarter

-1.29

Avg. EPS Est. Next Quarter

-1.35

Insider Transactions

-29.53

Institutional Transactions

-0.22

Beta

2.03

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

11.1

Max Drawdown 5-Year %

-83

Target Price

145.22

P/E

Forward P/E

PEG

P/S

106.2

P/B

6.72

P/Free Cash Flow

EPS

-3.62

Average EPS Est. Cur. Y

-3.93

EPS Next Y. (Est.)

-5.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-341.79

Relative Volume

0.83

Return on Equity vs Sector %

-48

Return on Equity vs Industry %

-28.6

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.09

EBIT Estimation

◆ KYMR Healthcare

$127.17

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

5/25

Volume

7/15

Valuation

5/20

TP/AR

4/10

Options

4/10

RSI

54.5

Range 1M

61.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

4/30

Estimates

3/20

Inst/Vol

2/15

Options

5/10

EPS Yr

-7%

EPS NY

-30%

52W%

81.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +14.2% upside

Quality

6/30

Valuation

4/30

Growth

1/25

Stability

7/10

LT Trend

1/5

Upside

+14.2%

Quality

KYMR — P/E HistoricalBiotechnology

Kymera Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 285

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing KT-621, an oral STAT6 degrader in Phase 2b clinical trials for moderate to severe atopic dermatitis, asthma, COPD, EoE, CRSwNP, CSU, PN, BP, and others; KT-579, an oral IRF5 degrader in Phase 1 trials for autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, SSc, DM, and others; KT-485/SAR447971, IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis; and cyclin-dependent kinase 2 (CDK2) with broad oncology treatment potential, including in breast cancer and other solid tumors. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

KYMR

Latest News

—

Caricamento notizie per KYMR…

stock quote shares KYMR – Kymera Therapeutics, Inc. Stock Price stock today

news today KYMR – Kymera Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch KYMR – Kymera Therapeutics, Inc. yahoo finance google finance

stock history KYMR – Kymera Therapeutics, Inc. invest stock market

stock prices KYMR premarket after hours

ticker KYMR fair value insiders trading

KYMR – Kymera Therapeutics, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: KYMR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y